Filing Details
CHAMPIONS ONCOLOGY, INC. (NASDAQ:CSBR) filed a Form 8-K with the Securities and Exchange Commission on October 16, 2026, disclosing a material event.
8k filedNASDAQ:CSBR
CHAMPIONS ONCOLOGY, INC. (CSBR) Reports Material Event to SEC
CHAMPIONS ONCOLOGY, INC. (NASDAQ:CSBR) filed a Form 8-K with the Securities and Exchange Commission on October 16, 2026, disclosing a material event.
At publication ·
What changed
CHAMPIONS ONCOLOGY, INC. (NASDAQ:CSBR) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Champions Oncology filed a Form 8-K with the SEC on October 16, 2026, disclosing a material event requiring shareholder attention.
- The company's stock trades at $4.70 with a market capitalization of $87.1 million.
- Material events reported in 8-K filings can include leadership changes, acquisitions, asset sales, or financial guidance adjustments.
Market Context
CHAMPIONS ONCOLOGY, INC.'s stock currently trades at $4.70 with a market capitalization of $87.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CHAMPIONS ONCOLOGY, INC.'s stock.
All SEC filings for CHAMPIONS ONCOLOGY, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CSBR Stock Page
Frequently Asked Questions
Where can I read CSBR's SEC filings?
Browse all filings on our CSBR SEC filings page.
What types of SEC filings does CHAMPIONS ONCOLOGY, INC. file?
Public companies like CHAMPIONS ONCOLOGY, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.